Cargando…
Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports
BACKGROUND: Identifying men for a repeat prostate biopsy is a conundrum to urologists. Risk calculators (RCs) such as the European Randomized Study of Screening for Prostate Cancer (ERSPC) RCs have been developed to predict the outcome of prostate biopsies and have been shown to improve diagnostic a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884880/ https://www.ncbi.nlm.nih.gov/pubmed/31783839 http://dx.doi.org/10.1186/s12894-019-0561-6 |